Non Small Cell Lung Carcinoma
2 competing products in clinical development for Non Small Cell Lung Carcinoma.
Pipeline by Phase
Phase 21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pemetrexed + Carboplatin | Eli Lilly | Phase 3 | Completed | 77 |
| Enzastaurin HCL | Eli Lilly | Phase 2 | Completed | 52 |